BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 9358102)

  • 1. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
    Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.
    Giorgi JV; Liu Z; Hultin LE; Cumberland WG; Hennessey K; Detels R
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):904-12. PubMed ID: 7686224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable.
    Froebel KS; Raab GM; D'Alessandro C; Armitage MP; MacKenzie KM; Struthers M; Whitelaw JM; Yang S
    Clin Exp Immunol; 2000 Oct; 122(1):72-8. PubMed ID: 11012621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes.
    Plaeger S; Bass HZ; Nishanian P; Thomas J; Aziz N; Detels R; King J; Cumberland W; Kemeny M; Fahey JL
    Clin Immunol; 1999 Feb; 90(2):238-46. PubMed ID: 10080836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
    de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
    Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group.
    Giorgi JV; Ho HN; Hirji K; Chou CC; Hultin LE; O'Rourke S; Park L; Margolick JB; Ferbas J; Phair JP
    J Infect Dis; 1994 Oct; 170(4):775-81. PubMed ID: 7930717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
    Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
    Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients.
    Mocroft A; Bofill M; Lipman M; Medina E; Borthwick N; Timms A; Batista L; Winter M; Sabin CA; Johnson M; Lee CA; Phillips A; Janossy G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):158-62. PubMed ID: 9052725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator.
    Hultin LE; Matud JL; Giorgi JV
    Cytometry; 1998 Oct; 33(2):123-32. PubMed ID: 9773872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency.
    Liu Z; Cumberland WG; Hultin LE; Kaplan AH; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):332-40. PubMed ID: 9704938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up.
    Liu Z; Hultin LE; Cumberland WG; Hultin P; Schmid I; Matud JL; Detels R; Giorgi JV
    Cytometry; 1996 Mar; 26(1):1-7. PubMed ID: 8809474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients.
    Sherman GG; Scott LE; Galpin JS; Kuhn L; Tiemessen CT; Simmank K; Meddows-Taylor S; Meyers TM
    Pediatr Res; 2002 Jun; 51(6):740-5. PubMed ID: 12032270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
    Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
    J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive infection in a subset of HIV-1-positive chimpanzees.
    O'Neil SP; Novembre FJ; Hill AB; Suwyn C; Hart CE; Evans-Strickfaden T; Anderson DC; deRosayro J; Herndon JG; Saucier M; McClure HM
    J Infect Dis; 2000 Oct; 182(4):1051-62. PubMed ID: 10979899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV/AIDS patients].
    Xie J; Qiu Z; Han Y; Li Y; Song X; Li T
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):36-9. PubMed ID: 26796651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.